As levels of p-tau and Aβ did not differ between EPVS levels in patients with PD, and the effects of EPVS on CSF proteins were not replicated in HCs, the current findings indicated disease-specific PVS dysfunction in patients with PD. Here, MAPT is linked to Parkinson disease.